U.S. Defense Secretary Pete Hegseth announced a new policy Wednesday requiring mandatory annual testosterone screenings for all military personnel aged 30 and older. The initiative, which Hegseth promoted on social media under the banner “High-T Department,” aims to address hormone deficiency among the force to ensure troops remain “strong, resilient and capable.”
Under the new guidelines, service members under 30 may volunteer for testing. While the Pentagon has emphasized that any subsequent hormone replacement therapy (HRT) will be strictly voluntary, the policy marks a significant shift in military medical standards. Hegseth stated the move is “not about artificial enhancement” but rather about “restoring and optimizing natural capabilities” to maintain the “individual warfighter” as the military’s most decisive asset.
Medical and Policy Implications
The announcement follows a broader trend within the current administration, led by Health Secretary Robert F. Kennedy Jr., to increase access to testosterone therapies. Recently, the FDA proposed loosening prescribing limits on testosterone products, moving away from strict requirements that limited use to patients with diagnosed hypogonadism.
However, the military policy has drawn sharp criticism from medical experts and lawmakers. Standard medical guidelines typically advise against blanket screening, recommending testing only for individuals who present with specific, documented symptoms. Critics warn that indiscriminate testing and potential HRT could lead to unintended health consequences, including cardiovascular risks and infertility, particularly for younger service members.
Political Controversy
The policy has ignited a fierce political firestorm. Democratic lawmakers, including Senator Tammy Duckworth and Representative Chrissy Houlahan, have criticized the move as a “culture-war obsession” that caters to the “manosphere.” Critics point to the irony of the Pentagon prioritizing male hormone optimization while potentially neglecting similar health concerns for women in uniform, such as menopause or fertility support.
The Pentagon has not yet clarified whether female service members will receive equivalent access to hormone-based health screenings, nor has it released the specific research underpinning the decision. This lack of transparency, coupled with Hegseth’s previous efforts to restrict combat roles for women, has fueled accusations that the policy is ideologically driven rather than medically necessitated.